Cell Line Models for Acquired Resistance to First-Line Osimertinib in Lung Cancers—Applications and Limitations

por Ohara, Shuta, Suda, Kenichi, Mitsudomi, Tetsuya
Publicado 2021

Foretinib can overcome common on-target resistance mutations after capmatinib/tepotinib treatment in NSCLCs with MET exon 14 skipping mutation

por Fujino, Toshio, Suda, Kenichi, Koga, Takamasa, Hamada, Akira, Ohara, Shuta, Chiba, Masato, Shimoji, Masaki, Takemoto, Toshiki, Soh, Junichi, Mitsudomi, Tetsuya
Publicado 2022

Activity of tarloxotinib‐E in cells with EGFR exon‐20 insertion mutations and mechanisms of acquired resistance

por Nishino, Masaya, Suda, Kenichi, Koga, Takamasa, Ohara, Shuta, Fujino, Toshio, Soh, Junichi, Tirunagaru, Vijaya, Vellanki, Avanish, Doebele, Robert C., Mitsudomi, Tetsuya
Publicado 2021

Activity and mechanism of acquired resistance to tarloxotinib in HER2 mutant lung cancer: an in vitro study

por Koga, Takamasa, Suda, Kenichi, Nishino, Masaya, Fujino, Toshio, Ohara, Shuta, Hamada, Akira, Soh, Junichi, Tirunagaru, Vijaya, Vellanki, Avanish, Doebele, Robert C., Mitsudomi, Tetsuya
Publicado 2021

Prognostic implications of preoperative versus postoperative circulating tumor DNA in surgically resected lung cancer patients: a pilot study

por Ohara, Shuta, Suda, Kenichi, Sakai, Kazuko, Nishino, Masaya, Chiba, Masato, Shimoji, Masaki, Takemoto, Toshiki, Fujino, Toshio, Koga, Takamasa, Hamada, Akira, Soh, Junichi, Nishio, Kazuto, Mitsudomi, Tetsuya
Publicado 2020

Clinical Relevance of Patient-Derived Organoid of Surgically Resected Lung Cancer as an In Vitro Model for Biomarker and Drug Testing

por Koga, Takamasa, Soh, Junichi, Hamada, Akira, Miyano, Yuki, Fujino, Toshio, Obata, Keiko, Ohara, Shuta, Nishino, Masaya, Chiba, Masato, Shimoji, Masaki, Takemoto, Toshiki, Suda, Kenichi, Sakai, Kazuko, Sato, Hidenori, Mitsudomi, Tetsuya
Publicado 2023

Primary pulmonary mucosa-associated lymphoid tissue lymphoma with amyloid light chain-type amyloidosis

por Ohara, Shuta, Tomizawa, Kenji, Shimizu, Shigeki, Suda, Kenichi, Fujino, Toshio, Hamada, Akira, Koga, Takamasa, Nishino, Masaya, Kobayashi, Yoshihisa, Sato, Katsuaki, Chiba, Masato, Shimoji, Masaki, Takemoto, Toshiki, Soh, Junichi, Mitsudomi, Tetsuya
Publicado 2019

Presence of a Ground-Glass Opacity Component Is the True Prognostic Determinant in Clinical Stage I NSCLC

por Hamada, Akira, Suda, Kenichi, Fujino, Toshio, Nishino, Masaya, Ohara, Shuta, Koga, Takamasa, Kabasawa, Takanobu, Chiba, Masato, Shimoji, Masaki, Endoh, Makoto, Takemoto, Toshiki, Soh, Junichi, Yanagawa, Naoki, Shiono, Satoshi, Mitsudomi, Tetsuya
Publicado 2022